Magenta Life

How has been the historical performance of the Magenta Life?

Magenta Life's historical performance shows declining net sales from Rs 9.24 crore in March 2022 to Rs 8.76 crore in March 2024, but profitability metrics improved, with profit after tax rising to Rs 0.74 crore and earnings per share increasing to Rs 1.52. Overall, while sales decreased, operational efficiency has enhanced profitability.

Answer:<BR>The historical performance of Magenta Life shows a mixed trend in financial metrics over the past three years.<BR><BR>Breakdown:<BR>In terms of net sales, Magenta Life reported Rs 8.76 crore in March 2024, a decline from Rs 9.07 crore in March 2023 and Rs 9.24 crore in March 2022. The total operating income mirrored this trend, remaining at Rs 8.76 crore in March 2024, down from Rs 9.07 crore in the previous year. Raw material costs decreased to Rs 5.38 crore in March 2024 from Rs 6.01 crore in March 2023, contributing to a total expenditure of Rs 7.27 crore, which also saw a reduction from Rs 8.20 crore in March 2023. Operating profit, excluding other income, improved to Rs 1.49 crore in March 2024 from Rs 0.87 crore in March 2023, leading to an overall operating profit of Rs 1.77 crore in March 2024. Profit before tax rose significantly to Rs 1.02 crore in March 2024 from Rs 0.32 crore in March 2023, resulting in a profit after tax of Rs 0.74 crore, up from Rs 0.25 crore the previous year. The earnings per share also increased to Rs 1.52 in March 2024 from Rs 0.54 in March 2023. On the balance sheet, total liabilities rose to Rs 13.06 crore in March 2024 from Rs 12.51 crore in March 2023, while total assets increased slightly to Rs 13.06 crore from Rs 12.51 crore. Cash flow from operating activities remained at Rs 0.00 for March 2024, indicating no cash inflow or outflow from operations during the year. Overall, while sales have declined, profitability metrics have shown improvement, reflecting a positive trend in operational efficiency.

Who are the top shareholders of the Magenta Life?

The top shareholder of Magenta Life is Divyesh Vipinchandra Modi, holding 31.42%. Other significant shareholders include 7nr Retail Limited at 6.11% and individual investors with a combined 30.02%.

The top shareholders of Magenta Life include the promoters, with Divyesh Vipinchandra Modi holding the largest stake at 31.42%. There are no pledged promoter holdings, and mutual funds and foreign institutional investors do not hold any shares in the company. The highest public shareholder is 7nr Retail Limited, which owns 6.11%. Additionally, individual investors collectively hold 30.02% of the shares.

how big is Magenta Life?

As of Jun 06, Magenta Lifecare Ltd has a market capitalization of 11.00 Cr, classifying it as a Micro Cap company. There is no available financial data for the latest four quarters, but as of Mar'24, shareholder's funds are reported at 6.84 Cr and total assets at 13.06 Cr.

As of Jun 06, Magenta Lifecare Ltd has a market capitalization of 11.00 Cr, categorizing it as a Micro Cap company.<BR><BR>As of Jun 06, there is no valid Consolidated or Standalone financial data available for the latest four quarters, including Net Sales and Net Profit.<BR><BR>As of Mar'24, the Balance Sheet Snapshot is based on Standalone data for the latest annual period. Shareholder's Funds are reported at 6.84 Cr, and Total Assets amount to 13.06 Cr.

Has Magenta Life declared dividend?

No Dividend History Available

Is Magenta Life overvalued or undervalued?

As of June 2, 2025, Magenta Life's valuation has shifted to risky, indicating it is overvalued with a PE ratio of 10.52 and a year-to-date return of -36.4%, underperforming compared to the Sensex's 5.54%.

As of 2 June 2025, the valuation grade for Magenta Life has moved from does not qualify to risky, indicating a significant shift in its perceived investment quality. The company appears to be overvalued based on its current financial ratios, which include a PE ratio of 10.52, a Price to Book Value of 1.54, and an EV to EBIT of -13.60. These figures suggest that the market may not be accurately reflecting the company's underlying financial health.<BR><BR>In comparison to its peers, Magenta Life's valuation stands out unfavorably. For instance, Metro Brands is categorized as very expensive with a PE ratio of 95.29, while V-Guard Industries Ltd. is rated fair with a PE of 52.15. The stark contrast in valuations highlights that Magenta Life may not be justified at its current price level. Additionally, the company's stock has underperformed relative to the Sensex, with a year-to-date return of -36.4% compared to the Sensex's 5.54%, reinforcing the notion that it is overvalued in the current market context.

What is the technical trend for Magenta Life?

As of May 9, 2025, Magenta Life's technical trend is mildly bearish, influenced by bearish daily moving averages and Bollinger Bands, despite a mildly bullish weekly MACD and a mixed outlook from Dow Theory.

As of 9 May 2025, the technical trend for Magenta Life has changed from does not qualify to mildly bearish. The current technical stance is mildly bearish, driven by several key indicators. The weekly MACD is mildly bullish, but the daily moving averages are bearish, indicating short-term weakness. The weekly Bollinger Bands also reflect a bearish sentiment. Additionally, the Dow Theory shows a mildly bearish stance on the weekly timeframe, while the monthly perspective is mildly bullish. Overall, the mixed signals suggest a cautious outlook, with bearish tendencies prevailing in the short term.

Who are the peers of the Magenta Life?

Magenta Life's peers include Sheela Foam, Responsive Industries, Stanley Lifestyle, BirlaNu Ltd, Hardwyn India, Tirupati Foam, Shashwat Furnishings, Milestone Furnishings, and Rexpro Enterprises. Magenta Life has below-average management and capital structure risks, with a 1-year return of -63.48%, significantly underperforming its peers.

Peers: The peers of Magenta Life are Sheela Foam, Responsive Ind, Stanley Lifesty., BirlaNu Ltd, Hardwyn India, Tirupati Foam, Shashwat Furnis., Milestone Furn., and Rexpro Enter.<BR><BR>Quality Snapshot: Excellent management risk is observed at Rexpro Enter, while Average management risk is found at Sheela Foam, Responsive Ind, Stanley Lifesty., BirlaNu Ltd, Hardwyn India, and the rest. Below Average management risk is noted for Tirupati Foam, Shashwat Furnis., and Magenta Life. In terms of growth, Excellent growth is seen at Responsive Ind, while Average growth is noted for Shashwat Furnis. Below Average growth is found at Sheela Foam, Stanley Lifesty., BirlaNu Ltd, Hardwyn India, Tirupati Foam, Magenta Life, and the rest. For capital structure, Excellent capital structure is attributed to Hardwyn India, Good capital structure is seen at Sheela Foam, Responsive Ind, Stanley Lifesty., Shashwat Furnis., and the rest, while Average capital structure is noted for BirlaNu Ltd and Rexpro Enter, and Below Average capital structure is observed at Tirupati Foam, Magenta Life, and the rest.<BR><BR>Return Snapshot: Shashwat Furnis. has the highest 1-year return at 49.88%, while Magenta Life has the lowest at -63.48%. This indicates that Magenta Life's performance is significantly worse than its peers. Additionally, the six-month return is negative for Sheela Foam, Stanley Lifesty., Hardwyn India, Tirupati Foam, and Magenta Life.

What does Magenta Life do?

Magenta Lifecare Ltd is a micro-cap company in the furniture and home furnishing industry, recently transitioned to a public limited company in July 2023. Financial data for the latest quarter is unavailable, with a market cap of INR 10 Cr and a P/E ratio of 10.00.

Overview:<BR>Magenta Lifecare Ltd operates in the furniture and home furnishing industry and is categorized as a micro-cap company.<BR><BR>History:<BR>Magenta Lifecare Ltd was originally incorporated as "Magenta Lifecare Private Limited" on August 04, 2015. The company transitioned to a public limited company, changing its name to "Magenta Lifecare Limited," with a fresh Certificate of Incorporation issued on July 05, 2023. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 10 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 10.00<BR>Industry P/E: N/A<BR>Dividend Yield: 0.00%<BR>Debt-Equity: 0.45<BR>Return on Equity: 1.17%<BR>Price-to-Book: 1.53<BR><BR>Contact Details:<BR>Registrar Address: Not available.

When is the next results date for Magenta Lifecare Ltd?

The next results date for Magenta Lifecare Ltd is 28 May 2026.

The next results date for Magenta Lifecare Ltd is scheduled for 28 May 2026.

Why is Magenta Lifecare Ltd falling/rising?

As of 02-Jun, Magenta Lifecare Ltd's stock price is at 9.41, showing a year-to-date decline of 24.17% and a one-year decrease of 41.59%. The stock has underperformed its sector and is trading below key moving averages, indicating a bearish trend despite a recent increase in investor participation.

As of 02-Jun, Magenta Lifecare Ltd's stock price is currently at 9.41, with no change from the previous trading session. The stock has shown a significant decline over various time periods, with a year-to-date drop of 24.17% and a one-year decrease of 41.59%. This underperformance is starkly contrasted with the Sensex, which has only fallen by 12.40% over the same year-to-date period.<BR><BR>Today, the stock has underperformed its sector by 4.18%, indicating a weaker performance relative to its peers. Additionally, the stock has not traded on 2 out of the last 20 days, suggesting erratic trading behavior. It is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically signals a bearish trend.<BR><BR>On a slightly positive note, there has been a rise in investor participation, with a delivery volume increase of 25% on 27 May compared to the 5-day average. However, this increase in participation does not seem to be enough to counteract the overall downward trend in the stock's price.<BR><BR>In summary, the combination of significant declines over multiple time frames, underperformance against the sector, and trading below key moving averages are the primary factors contributing to the falling stock price of Magenta Lifecare Ltd.

Which are the latest news on Magenta Life?